Vitrolife
214,4 SEK -1,56 %Vær den første som følger denne virksomhed
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Omsætning
3,23 mia.
EBIT %
20,22 %
P/E
73,68
Udbytteafkast, %
0,4 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VITR
Daglig lav / høj pris
213,4 / 217,6
SEK
Markedsværdi
29,04 mia. SEK
Aktieomsætning
12,36 mio. SEK
Volumen
57 t
Finanskalender
Delårsrapport
14.07.2023
Delårsrapport
27.10.2023
Årsrapport
02.02.2024
Viser Alle indholdstyper